Bliss GVS Pharma Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bliss GVS Pharma has informed exchanges that a defendant has filed an appeal in the Superior Court of Judicature in Accra, Ghana against a previous ruling. Earlier, on April 15, 2025, the High Court of Justice in Accra had ruled in favour of Bliss GVS Pharma in a commercial suit concerning infringement of intellectual property rights, and the defendant's counterclaim was dismissed in full. The company has now disclosed the appeal filed by the defendant against that order, with the defendant's name withheld to protect the company's interests. The company stated it will provide further updates as the case progresses.
This is a procedural update and not a fresh adverse ruling. The original judgment favoured the company, but the appeal introduces some uncertainty around the final outcome, which investors should track for any material developments.